Roland D Reinhart, M.D. Anesthesiology - Pain Medicine Medicare: Accepting Medicare Assignments Practice Location: 39800 Portola Ave, Palm Desert, CA 92260 Phone: 760-341-2360 Fax: 760-346-5940 |
Dr. Craig Steven Rosenblum, M.D. Anesthesiology - Pain Medicine Medicare: Not Enrolled in Medicare Practice Location: 73950 Alessandro Dr, Suite 2, Palm Desert, CA 92260 Phone: 760-346-5911 Fax: 760-346-5812 |
Victor Victorov, M.D. Anesthesiology Medicare: Not Enrolled in Medicare Practice Location: 74051 Kokopelli Cir, Palm Desert, CA 92211 Phone: 760-341-4178 |
Dilangani Ratnayake, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 73733 Fred Waring Dr Ste 205, Palm Desert, CA 92260 Phone: 760-895-4280 Fax: 760-408-5817 |
News Archive
YM BioSciences Inc., is presenting posters on its JAK1/2 inhibiting small molecule (CYT387) and on its novel vascular disrupting agent (CYT997) at the Lorne Cancer Conference in Lorne, Victoria, Australia. CYT387 is an oral JAK1/2 inhibitor, originating from the seminal discovery of JAK1 and JAK2 kinases by Dr. Andrew Wilks, the founder of Cytopia Limited, now YM Australia. CYT997 is an orally-available agent with dual mechanisms of vascular disruption and cytotoxicity and has the potential to be broadly active against a range of tumor types.
Winnie Palmer Hospital for Women & Babies is launching a new blog for health and wellness called According to Winnie, an informative and interactive online community where women can join conversations on healthcare, prevention and wellness, dieting, recipes, family health, and more.
The Johns Hopkins Bloomberg School of Public Health has received $28 million in grants from the Bill & Melinda Gates Foundation, the David and Lucile Packard Foundation and the William and Flora Hewlett Foundation to continue and expand the Advance Family Planning advocacy initiative within the Bloomberg School's Bill & Melinda Gates Institute on Population and Reproductive Health.
Morinaga Milk Industry Co., Ltd., the second largest dairy product company in Japan, today announced that the U.S. Food and Drug Administration has issued Generally Recognized as Safe Letters of No Objection for Morinaga's proprietary probiotic strain, Bifidobacterium breve M-16V for food applications and infant formulas.
Valeant Pharmaceuticals International, Inc. announced today that its subsidiary, Biovail Laboratories International SRL (BLS), has agreed to acquire several privately–owned pharmacy skin care brands in Australia. The leading brands, including well-established local brands such as Hamilton's Suncare and Hamilton's Skin Therapy, are ranked #2 in suncare in the Australian pharmacy market.
› Verified 7 days ago